Show simple item record

dc.contributor.authorNeymotin, Samuel A
dc.contributor.authorDura-Bernal, Salvador
dc.contributor.authorMoreno, Herman
dc.contributor.authorLytton, William W
dc.date.accessioned2023-04-10T16:33:52Z
dc.date.available2023-04-10T16:33:52Z
dc.date.issued2017-03-31
dc.identifier.citationNeymotin SA, Dura-Bernal S, Moreno H, Lytton WW. Computer modeling for pharmacological treatments for dystonia. Drug Discov Today Dis Models. 2016 Spring;19:51-57. doi: 10.1016/j.ddmod.2017.02.003. Epub 2017 Mar 31. PMID: 28983321; PMCID: PMC5624716.en_US
dc.identifier.issn1740-6757
dc.identifier.doi10.1016/j.ddmod.2017.02.003
dc.identifier.pmid28983321
dc.identifier.urihttp://hdl.handle.net/20.500.12648/8571
dc.description.abstractDystonia is a movement disorder that produces involuntary muscle contractions. Current pharmacological treatments are of limited efficacy. Dystonia, like epilepsy is a disorder involving excessive activty of motor areas including motor cortex and several causal gene mutations have been identified. In order to evaluate potential novel agents for multitarget therapy for dystonia, we have developed a computer model of cortex that includes some of the complex array of molecular interactions that, along with membrane ion channels, control cell excitability.
dc.language.isoenen_US
dc.relation.urlhttps://www.sciencedirect.com/science/article/abs/pii/S1740675717300099en_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleComputer modeling for pharmacological treatments for dystonia.en_US
dc.typeArticle/Reviewen_US
dc.source.journaltitleDrug discovery today. Disease modelsen_US
dc.source.volume19
dc.source.beginpage51
dc.source.endpage57
dc.source.countryUnited States
dc.source.countryUnited States
dc.source.countryUnited States
dc.source.countryNetherlands
dc.description.versionAMen_US
refterms.dateFOA2023-04-10T16:33:53Z
html.description.abstractDystonia is a movement disorder that produces involuntary muscle contractions. Current pharmacological treatments are of limited efficacy. Dystonia, like epilepsy is a disorder involving excessive activty of motor areas including motor cortex and several causal gene mutations have been identified. In order to evaluate potential novel agents for multitarget therapy for dystonia, we have developed a computer model of cortex that includes some of the complex array of molecular interactions that, along with membrane ion channels, control cell excitability.
dc.description.institutionSUNY Downstateen_US
dc.description.departmentPhysiology and Pharmacologyen_US
dc.description.departmentNathan Kline Institute for Psychiatric Researchen_US
dc.description.degreelevelN/Aen_US
dc.identifier.journalDrug discovery today. Disease models


Files in this item

Thumbnail
Name:
Publisher version
Thumbnail
Name:
nihms858924.pdf
Size:
1.504Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International